Liberum Capital’s Joachim Klement tells IG’s @AngelineOng why tech and mining are likely to do well in the latter half of 2024. In the first half? Joachim says MedTech stocks, related to kidney disease, will offer investors healthy returns.
Any opinion, news, research, analysis, or other information does not constitute investment or trading advice.
Follow us on Twitter), Instagram), and YouTube)
Your capital is at risk. 68% of retail CFD accounts lose money
